4//SEC Filing
POST LEONARD E 4
Accession 0001235862-25-000003
CIK 0001991792other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:30 PM ET
Size
8.1 KB
Accession
0001235862-25-000003
Insider Transaction Report
Form 4
POST LEONARD E
Director
Transactions
- Sale
Common Stock
2025-09-03$28.00/sh−1,000$28,000→ 0 total - Exercise/Conversion
Common Stock
2025-09-03$0.60/sh+1,000$600→ 1,000 total - Exercise/Conversion
Director Stock Option (right to buy)
2025-09-03−1,000→ 125,077 totalExercise: $0.60Exp: 2028-07-08→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.
- [F2]Fully vested
Documents
Issuer
CG Oncology, Inc.
CIK 0001991792
Entity typeother
Related Parties
1- filerCIK 0001235862
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:30 PM ET
- Size
- 8.1 KB